Abstract
During the past two decades, a number of variable genetic sequences have been uncovered that permit molecular typing of Mycobacterium tuberculosis complex (MTC) organisms. Since the determination of the M. tuberculosis, and later M. bovis, genome sequences, the nature of these variable genetic sequences has become more evident, permitting a clearer recognition of which molecular tools lend themselves best to certain applications. In this review, ‘classical’ genotyping methods for molecular epidemiologic uses are briefly discussed, followed by a more detailed description of post-genomic typing methods, including large sequence polymorphisms otherwise referred to as genomic deletions. Because genomic deletions represent unique event polymorphisms not prone to reversion, these mutations effectively ‘brand’ bacterial lineages, including species/subspecies of the MTC and specific clades of M. tuberculosis sensu stricto. Genomic deletions therefore provide a new opportunity to accurately classify organisms for diagnostic and epidemiologic purposes, serving as the basis for further study of the natural variability across MTC organisms.
Keywords: Molecular typing, DNA sequence polymorphisms, genomic deletions
Current Molecular Medicine
Title: Molecular Tools for Typing and Branding the Tubercle Bacillus
Volume: 7 Issue: 3
Author(s): Marcel A. Behr and Serge Mostowy
Affiliation:
Keywords: Molecular typing, DNA sequence polymorphisms, genomic deletions
Abstract: During the past two decades, a number of variable genetic sequences have been uncovered that permit molecular typing of Mycobacterium tuberculosis complex (MTC) organisms. Since the determination of the M. tuberculosis, and later M. bovis, genome sequences, the nature of these variable genetic sequences has become more evident, permitting a clearer recognition of which molecular tools lend themselves best to certain applications. In this review, ‘classical’ genotyping methods for molecular epidemiologic uses are briefly discussed, followed by a more detailed description of post-genomic typing methods, including large sequence polymorphisms otherwise referred to as genomic deletions. Because genomic deletions represent unique event polymorphisms not prone to reversion, these mutations effectively ‘brand’ bacterial lineages, including species/subspecies of the MTC and specific clades of M. tuberculosis sensu stricto. Genomic deletions therefore provide a new opportunity to accurately classify organisms for diagnostic and epidemiologic purposes, serving as the basis for further study of the natural variability across MTC organisms.
Export Options
About this article
Cite this article as:
Behr A. Marcel and Mostowy Serge, Molecular Tools for Typing and Branding the Tubercle Bacillus, Current Molecular Medicine 2007; 7 (3) . https://dx.doi.org/10.2174/156652407780598593
DOI https://dx.doi.org/10.2174/156652407780598593 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The First Kinetic Enzymatic Resolution of Methyl Ester of C75
Letters in Organic Chemistry Preface (Hot Topic: New Frontiers and ”Pitfalls“ in Cytokine and Anti-cytokine Therapies Executive Editor: Atsushi Oda)
Current Pharmaceutical Design Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design The Fungal Metabolites with Potential Antiplasmodial Activity
Current Medicinal Chemistry NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design
Current Medicinal Chemistry Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges
Recent Patents on Anti-Infective Drug Discovery Synthesis, Biological Profile, and Molecular Docking of Some New Bis- Imidazole Fused Templates and Investigation of their Cytotoxic Potential as Anti-tubercular and/or Anticancer Prototypes
Medicinal Chemistry Evidence for Conservative Treatment of Adolescent Idiopathic Scoliosis – Update 2015 (Mini-Review)
Current Pediatric Reviews Computational Simulations of the Immune System for Personalized Medicine: State of the Art and Challenges
Current Pharmacogenomics and Personalized Medicine Trypanosomatid Parasites Causing Neglected Diseases
Current Medicinal Chemistry Exploring Pyrimidine Pharmacophore as Thymidine Monophosphate Kinase Inhibitors for Antitubercular Activity: A Review
Current Topics in Medicinal Chemistry Aryl- and Heteroaryl-Thiosemicarbazone Derivatives and Their Metal Complexes: A Pharmacological Template
Recent Patents on Anti-Cancer Drug Discovery Uveitis in Rheumatic Diseases
Current Rheumatology Reviews Bedside Balance Testing in Elderly People
Current Aging Science Cancer Immunotherapy: Battling Tumors with Gene Vaccines
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Diversity in Medicinal Chemistry Space
Current Topics in Medicinal Chemistry Gauging Reactive Metabolites in Drug-Induced Toxicity
Current Medicinal Chemistry Cationic Liposomes as Non-viral Vector for RNA Delivery in Cancer Immunotherapy
Recent Patents on Drug Delivery & Formulation Immune Stimulatory Strategies for the Prevention and Treatment of Asthma
Current Pharmaceutical Design Editorial
Current Molecular Medicine